This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sin, J.-I.
Right arrow Articles by Weiner, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sin, J.-I.
Right arrow Articles by Weiner, D. B.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 501-509, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

Jeong-Im Sin,1 Jong J. Kim,1 Jean D. Boyer,1 Richard B. Ciccarelli,2 Terry J. Higgins,2 and David B. Weiner1,*

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,1 and WLVP, Malvern, Pennsylvania 193552

Received 1 July 1998/Accepted 1 September 1998

Several vaccines have been investigated experimentally in the herpes simplex virus type 2 (HSV-2) model system. While it is believed that CD4+-T-cell responses are important for protection in general, the correlates of protection from HSV-2 infection are still under investigation. Recently, the use of molecular adjuvants to drive vaccine responses induced by DNA vaccines has been reported in a number of experimental systems. We sought to take advantage of this immunization model to gain insight into the correlates of immune protection in the HSV-2 mouse model system and to further explore DNA vaccine technology. To investigate whether the Th1- or Th2-type immune responses are more important for protection from HSV-2 infection, we codelivered the DNA expression construct encoding the HSV-2 gD protein with the gene plasmids encoding the Th1-type (interleukin-2 [IL-2], IL-12, IL-15, and IL-18) and Th2-type (IL-4 and IL-10) cytokines in an effort to drive immunity induced by vaccination. We then analyzed the modulatory effects of the vaccine on the resulting immune phenotype and on the mortality and the morbidity of the immunized animals following a lethal challenge with HSV-2. We observed that Th1 cytokine gene coadministration not only enhanced the survival rate but also reduced the frequency and severity of herpetic lesions following intravaginal HSV challenge. On the other hand, coinjection with Th2 cytokine genes increased the rate of mortality and morbidity of the challenged mice. Moreover, of the Th1-type cytokine genes tested, IL-12 was a particularly potent adjuvant for the gD DNA vaccination.

* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, University of Pennsylvania, 505 Stellar-Chance Lab., 422 Curie Dr., Philadelphia, PA 19104. Phone: (215) 662-2352. Fax: (215) 573-9436. E-mail: dbweiner{at}mail.med.upenn.edu.

Journal of Virology, January 1999, p. 501-509, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sundling, C., Schon, K., Morner, A., Forsell, M. N. E., Wyatt, R. T., Thorstensson, R., Hedestam, G. B. K., Lycke, N. Y. (2008). CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization. J. Gen. Virol. 89: 2954-2964 [Abstract] [Full Text]  
  • Ljungberg, K., Whitmore, A. C., Fluet, M. E., Moran, T. P., Shabman, R. S., Collier, M. L., Kraus, A. A., Thompson, J. M., Montefiori, D. C., Beard, C., Johnston, R. E. (2007). Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine. J. Virol. 81: 13412-13423 [Abstract] [Full Text]  
  • Hu, H., Lu, X., Tao, L., Bai, B., Zhang, Z., Chen, Y., Zheng, F., Chen, J., Chen, Z., Wang, H. (2007). Induction of Specific Immune Responses by Severe Acute Respiratory Syndrome Coronavirus Spike DNA Vaccine with or without Interleukin-2 Immunization Using Different Vaccination Routes in Mice. CVI 14: 894-901 [Abstract] [Full Text]  
  • Herbst-Kralovetz, M. M., Pyles, R. B. (2006). Quantification of Poly(I:C)-Mediated Protection against Genital Herpes Simplex Virus Type 2 Infection.. J. Virol. 80: 9988-9997 [Abstract] [Full Text]  
  • Natuk, R. J., Cooper, D., Guo, M., Calderon, P., Wright, K. J., Nasar, F., Witko, S., Pawlyk, D., Lee, M., DeStefano, J., Tummolo, D., Abramovitz, A. S., Gangolli, S., Kalyan, N., Clarke, D. K., Hendry, R. M., Eldridge, J. H., Udem, S. A., Kowalski, J. (2006). Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4+ Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge. J. Virol. 80: 4447-4457 [Abstract] [Full Text]  
  • Osorio, Y., Ghiasi, H. (2005). Recombinant Herpes Simplex Virus Type 1 (HSV-1) Codelivering Interleukin-12p35 as a Molecular Adjuvant Enhances the Protective Immune Response against Ocular HSV-1 Challenge. J. Virol. 79: 3297-3308 [Abstract] [Full Text]  
  • Matsui, M., Moriya, O., Belladonna, M. L., Kamiya, S., Lemonnier, F. A., Yoshimoto, T., Akatsuka, T. (2004). Adjuvant Activities of Novel Cytokines, Interleukin-23 (IL-23) and IL-27, for Induction of Hepatitis C Virus-Specific Cytotoxic T Lymphocytes in HLA-A*0201 Transgenic Mice. J. Virol. 78: 9093-9104 [Abstract] [Full Text]  
  • Giri, M., Ugen, K. E., Weiner, D. B. (2004). DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade. Clin. Microbiol. Rev. 17: 370-389 [Abstract] [Full Text]  
  • Osorio, Y., Ghiasi, H. (2003). Comparison of Adjuvant Efficacy of Herpes Simplex Virus Type 1 Recombinant Viruses Expressing TH1 and TH2 Cytokine Genes. J. Virol. 77: 5774-5783 [Abstract] [Full Text]  
  • Koelle, D. M., Corey, L. (2003). Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research. Clin. Microbiol. Rev. 16: 96-113 [Abstract] [Full Text]  
  • van Rooij, E. M. A., Glansbeek, H. L., Hilgers, L. A. T., te Lintelo, E. G., de Visser, Y. E., Boersma, W. J. A., Haagmans, B. L., Bianchi, A. T. J. (2002). Protective Antiviral Immune Responses to Pseudorabies Virus Induced by DNA Vaccination Using Dimethyldioctadecylammonium Bromide as an Adjuvant. J. Virol. 76: 10540-10545 [Abstract] [Full Text]  
  • Glansbeek, H. L., Haagmans, B. L., te Lintelo, E. G., Egberink, H. F., Duquesne, V., Aubert, A., Horzinek, M. C., Rottier, P. J. M. (2002). Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J. Gen. Virol. 83: 1-10 [Abstract] [Full Text]  
  • Hanlon, L., Argyle, D., Bain, D., Nicolson, L., Dunham, S., Golder, M. C., McDonald, M., McGillivray, C., Jarrett, O., Neil, J. C., Onions, D. E. (2001). Feline Leukemia Virus DNA Vaccine Efficacy Is Enhanced by Coadministration with Interleukin-12 (IL-12) and IL-18 Expression Vectors. J. Virol. 75: 8424-8433 [Abstract] [Full Text]  
  • Nakajima, H., Kobayashi, M., Pollard, R. B., Suzuki, F. (2001). Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J. Leukoc. Biol. 70: 374-380 [Abstract] [Full Text]  
  • Niethammer, A. G., Xiang, R., Ruehlmann, J. M., Lode, H. N., Dolman, C. S., Gillies, S. D., Reisfeld, R. A. (2001). Targeted Interleukin 2 Therapy Enhances Protective Immunity Induced by an Autologous Oral DNA Vaccine against Murine Melanoma. Cancer Res. 61: 6178-6184 [Abstract] [Full Text]  
  • Mattei, F., Schiavoni, G., Belardelli, F., Tough, D. F. (2001). IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation. J. Immunol. 167: 1179-1187 [Abstract] [Full Text]  
  • Chen, H.-W., Pan, C.-H., Huan, H.-W., Liau, M.-Y., Chiang, J.-R., Tao, M.-H. (2001). Suppression of Immune Response and Protective Immunity to a Japanese Encephalitis Virus DNA Vaccine by Coadministration of an IL-12-Expressing Plasmid. J. Immunol. 166: 7419-7426 [Abstract] [Full Text]  
  • Harle, P., Noisakran, S., Carr, D. J. J. (2001). The Application of a Plasmid DNA Encoding IFN-{{alpha}}1 Postinfection Enhances Cumulative Survival of Herpes Simplex Virus Type 2 Vaginally Infected Mice. J. Immunol. 166: 1803-1812 [Abstract] [Full Text]  
  • Eo, S. K., Lee, S., Chun, S., Rouse, B. T. (2001). Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines. J. Virol. 75: 569-578 [Abstract] [Full Text]  
  • Fehniger, T. A., Caligiuri, M. A. (2001). Interleukin 15: biology and relevance to human disease. Blood 97: 14-32 [Full Text]  
  • Shedlock, D. J., Weiner, D. B. (2000). DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 68: 793-806 [Abstract] [Full Text]  
  • Sin, J.-I., Kim, J. J., Pachuk, C., Satishchandran, C., Weiner, D. B. (2000). DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo. J. Virol. 74: 11173-11180 [Abstract] [Full Text]  
  • Sin, J.-I., Kim, J., Patchuk, C., Weiner, D. B. (2000). Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo. CVI 7: 751-758 [Abstract] [Full Text]  
  • YAMADA, G., SHIJUBO, N., SHIGEHARA, K., OKAMURA, H., KURIMOTO, M., ABE, S. (2000). Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis. Am. J. Respir. Crit. Care Med. 161: 1786-1789 [Abstract] [Full Text]  
  • Kim, J. J., Yang, J.-S., VanCott, T. C., Lee, D. J., Manson, K. H., Wyand, M. S., Boyer, J. D., Ugen, K. E., Weiner, D. B. (2000). Modulation of Antigen-Specific Humoral Responses in Rhesus Macaques by Using Cytokine cDNAs as DNA Vaccine Adjuvants. J. Virol. 74: 3427-3429 [Abstract] [Full Text]  
  • Sin, J.-I., Ayyavoo, V., Boyer, J., Kim, J., Ciccarelli, R. B., Weiner, D. B. (1999). Protective immune correlates can segregate by vaccine type in a murine herpes model system. Int Immunol 11: 1763-1773 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»